Results 271 to 280 of about 10,142,751 (308)

The Effect of Obstruction and Perforation on Colorectal Cancer Disease‐Free Survival

World Journal of Surgery, 2010
AbstractBackgroundObstruction (OBSTR) and perforation (PERF) in colorectal cancer impact adversely upon outcomes, and cancer‐related survival may also be affected. However, data are sparse, particularly on disease‐free survival (DFS) where the cancer is both obstructed and perforated (OBS‐PERF).MethodsData were extracted from a prospectively collected ...
Ho, Yik-Hong, Siu, Simon K.K., Buttner, Petra, Stevenson, Andrew, Lumley, John, Stitz, Russel   +5 more
openaire   +5 more sources

Prognostic Value of Circulating Cytokines on Overall Survival and Disease-Free Survival in Cancer Patients

Biomarkers in Medicine, 2014
Through their tumor-promoting and/or tumor-suppressive properties, cytokines can influence progression of cancer. We systematically reviewed the current literature on the prognostic value of the circulating cytokines IL-1α/β, IL-6, IL-8, IL-10, IL-12, TNF-α, TGF-β and IFN-γ to predict overall and disease-free survival in any type of cancer patients ...
Visconti, Laura, Nelissen, Katherine, Deckx, Laura, van den Akker, Marjan, Adriaensen, Wim, Daniels, Liesbeth, Mathei, Cathy, Linsen, Loes, Hellings, Niels, Stinissen, Piet, Buntinx, Frank   +10 more
openaire   +5 more sources

Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study

Endocrine
Despite several factors that may have been associated with poor disease-free survival (DFS) in patients with medullary thyroid carcinoma (MTC), only a few studies have evaluated the prognostic factors affecting DFS in MTC patients. Therefore, this study evaluated the prognostic factors affecting DFS, in a large number of patients with MTC.Patients ...
Elbuken, Gulsah, BAYRAKTAROĞLU, TANER, AKALIN, AYSEN, KEBAPÇI, MEDİNE NUR, ÖZ GÜL, ÖZEN, ÇINAR, NEŞE, Niyazoglu, Mutlu, AKTÜRK, MÜJDE YAŞIM, Altuntas, Yuksel, TÜZÜN, DİLEK, GÜLDİKEN, SİBEL, Celik, Mehmet, Ciftci, Sema, ÖZDAMAR KARACA, ZÜLEYHA CİHAN, GÖNEN, MUSTAFA SAİT, KADIOĞLU, PINAR, Tuna, Mazhar Muslum, TOPÇU, BİROL, Tekin, Sakin, YORULMAZ, GÖKNUR, ATEŞ, COŞKUN, Akbaba, Gulhan, Burhan, Sebnem, PEKKOLAY, ZAFER, Sodan, Hulyanur, Catak, Merve, Erol, Selvinaz, KILINÇ, FARUK, Ozbay, Umit Nur, Andac, Burak, Karsli, Seda, AVCI, UĞUR, HACIOĞLU, AYŞA, UYSAL, SERHAT, Keskin, Umran, Ozturk, Beyza Olcay, ZUHUR, SAYİD SHAFİ   +36 more
openaire   +11 more sources

Surveillance and Screening During Disease-Free Survival

2008
After surgery for cancer of the spine, follow-up care to detect recurrence is an expected part of the overall postoperative care. Components of disease-free surveillance include periodic physical examinations, radiological studies, and blood work to follow or detect tumor markers.
Richard Placide, Kai-Uwe Lewandrowski, Robert F. McLain   +2 more
openaire   +1 more source

Disease‐free survival and recurrence after resection of colorectal carcinoma

Journal of Surgical Oncology, 1981
AbstractRecurrence Data From A Series Of 1, 315 Colorectal Cancer Patients Managed By One Surgeon With Potentially Curative Resection Are Presented. Complete Follow‐Up Information Was Available On 1, 287 (98%) Patients. At The Time Of The Last Recurrences, 164 And 232 Months For Rectal And Colonic Tumours Respectively, The Long‐Time Recurrence Rate Was
E, Pihl, E S, Hughes, F T, McDermott, B J, Milne, A B, Price   +4 more
openaire   +2 more sources

Long-term disease-free survival in immature teratoma of the ovary

Cancer, 1982
Long-term follow-up on five patients with immature teratoma of the ovary with residual metastatic Grade 0 disease following chemotherapy is reported. All five patients are free of progressive disease 40–96 months following original diagnosis. The concept of ‘retroconversion’ following chemotherapy for immature teratoma of the ovary is reemphasized ...
P, Dara, W M, Rich, K, Hodel, P J, DiSaia   +3 more
openaire   +2 more sources

Prognostic Nomogram for Disease-Free Survival in Patients with Renal Adenocarcinoma

Urologia Internationalis, 2012
<b><i>Objective:</i></b> The aim of this study was to develop a postoperative prognostic nomogram for disease-free survival in patients with renal adenocarcinoma. <b><i>Materials and Methods:</i></b> A total of 224 patients with organ-confined or locally advanced renal adenocarcinoma were treated with ...
Di Capua Sacoto, C., Budia, A., Garcia-Fadrique, G., Lujan, S., Ruiz-Cerda, J. L., Jimenez-Cruz, J. F.   +5 more
openaire   +3 more sources

Biochemical disease-free survival following 125I prostate implantation

International Journal of Radiation Oncology*Biology*Physics, 1997
To assess the 5-year clinical and biochemical results of ultrasound-guided permanent 125I brachytherapy in early adenocarcinoma of the prostate. Biochemical disease-free survival (BDFS) is reported, using PSA follow-up and is compared to the surgical and radiation therapy literature.From December 1988 through December 1993, ultrasound-guided ...
D C, Beyer, J B, Priestley
openaire   +2 more sources

Improved three-year disease-free survival in osteogenic sarcoma

The Journal of Bone and Joint Surgery. British volume, 1982
Of 41 consecutive patients with newly diagnosed osteogenic sarcoma admitted to the Children's Orthopedic Hospital and Medical Center in Seattle, Washington, between 1952 and 1977, 19 treated before 1973 did not receive adjunctive chemotherapy (histological group) whereas after 1972 22 have been so treated (chemotherapy group).
W A, Bleyer, J E, Haas, P, Feigl, T K, Greenlee, R T, Schaller, A, Morgan, T W, Pendergrass, F L, Johnson, I D, Bernstein, R L, Chard, J R, Hartmann   +10 more
openaire   +2 more sources

Diminished Disease-Free Survival After Lobectomy: Screening Implications

Clinical Lung Cancer, 2015
The aim of this study was to estimate the effect of lobectomy on life expectancy in healthy smokers and consider the implications for lung cancer screening.In a retrospective cohort study that provided a minimum of 15 years of follow-up, we analyzed lung cancer survival, all-cause survival, and fatality (1-survival) of 261 persons with stage I non ...
Jerome M, Reich, Jong S, Kim, James W, Asaph   +2 more
openaire   +2 more sources